NIH Coronavirus Disease 2019 (COVID-19) Treatment Guidelines: Important Resource for Clinicians

Content From: National Institutes of HealthPublished: April 01, 20211 min read


Cross-posted from


The National Institutes of Health’s Coronavirus Disease 2019 (COVID-19) Treatment Guidelines provide evidence-based guidance and recommendations for the care of patients with COVID-19. Developed by a panel of physicians and other experts from across the United States, the Guidelines are intended for clinicians who are caring for patients at all stages of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The recommendations in the Guidelines are based on COVID-related preprints, peer-reviewed articles, and other authoritative information, supplemented with the clinical experience of the Guidelines panel members.

The Guidelines focus on therapies for COVID-19, including antiviral drugs and immune-based therapies. Other topics discussed in the Guidelines include the clinical spectrum of SARS-CoV-2 infection, the care of critically ill patients with COVID-19, and special considerations for pregnant individuals and children with COVID-19.

The Guidelines are updated frequently to keep pace with the rapidly evolving information on the treatment of COVID-19. Please visit the COVID-19 Treatment Guidelines website to view the latest version of the Guidelines.